logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
SNSE
Sensei Biotherapeutics, Inc.
13.85
2 x 11.49
2 x 17.76
bid
ask
+
0.00
0.00%
04:00 PM
Ytd29.80%
1y85.16%
13.76
day range
16.52
6.33
52 week range
36.76
Open15.21Prev Close13.85Low13.76High16.52Mkt Cap18.59M
Vol219.47KAvg Vol52.33KEPS-142.72P/E-0.10Forward P/E-0.40
Beta0.06Short Ratio0.29Inst. Own8.81%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0850-d Avg21.49200-d Avg16.711yr Est4.13

SNSE News

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
businesswire.com
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an

AUSTIN, Texas--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that it

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
gurufocus.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on June 1, 2026, the Com

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
gurufocus.com
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial results for the first quarter e

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
businesswire.com
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial result

Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
businesswire.com
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breas

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology

Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
businesswire.com
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that Company ma

Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
businesswire.com
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial result

Sensei Biotherapeutics (SNSE) Expected to Announce Quarterly Earnings on Friday
defenseworld.net
Sensei Biotherapeutics (SNSE) Expected to Announce Quarterly Earnings on Friday

Sensei Biotherapeutics (NASDAQ: SNSE - Get Free Report) is expected to be announcing its Q4 2025 res

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
globenewswire.com
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology

VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider. com News Commentary

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Short Interest Up 1,973.5% in February
defenseworld.net
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Short Interest Up 1,973.5% in February

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE - Get Free Report) was the recipient of a large increase

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective

Nasdaq Surges Over 1%; US Durable Goods Orders Fall In December
benzinga.com
Nasdaq Surges Over 1%; US Durable Goods Orders Fall In December

Sensei Biotherapeutics Stock Soars 230% After Faeth Deal
feeds.benzinga.com
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal

SNSE up on acquisition of Faeth Therapeutics, $200M private placement, and addition of PIKTOR to pip

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
businesswire.com
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Priva

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that it has acq

Sensei Biotherapeutics (NASDAQ:SNSE) vs. Cynata Therapeutics (OTCMKTS:CYYNF) Critical Analysis
defenseworld.net
Sensei Biotherapeutics (NASDAQ:SNSE) vs. Cynata Therapeutics (OTCMKTS:CYYNF) Critical Analysis

Cynata Therapeutics (OTCMKTS:CYYNF - Get Free Report) and Sensei Biotherapeutics (NASDAQ: SNSE - Get

Egle Therapeutics Appoints John Celebi as Chief Executive Officer
globenewswire.com
Egle Therapeutics Appoints John Celebi as Chief Executive Officer

PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics SAS (Egle), a clinical-stage biotechnolog

What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump?
feeds.benzinga.com
What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump?

Sensei Biotherapeutics surged in after-hours trading Thursday, with strong recent gains and ongoing

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical st

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
globenewswire.com
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-st
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session